Docoh
Loading...

FACT Freedom Acquisition I

Filed: 2 Mar 21, 5:16pm

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):

March 2, 2021 (February 25, 2021)

FREEDOM ACQUISITION I CORP.
(Exact Name of Registrant as Specified in its Charter)

 

Cayman Islands 001-40117 N/A
(State or other jurisdiction
of incorporation)
 (Commission
File Number)
 (I.R.S. Employer
Identification No.)

 

14 Wall Street, 20th Floor

New York, New York

 

10005

(Address of Principal Executive Offices) (Zip Code)

 

Registrant’s telephone number, including area code: +1 212-618-1798

 

Not Applicable
(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading Symbol(s) Name of each exchange on which registered
Class A ordinary shares, par value $0.0001 per share FACT The New York Stock Exchange
Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 FACT WS The New York Stock Exchange
Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant FACT.U The New York Stock Exchange

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

 

 

 

Item 8.01. Other Events.

 

On March 2, 2021, Freedom Acquisition I Corp. (the “Company”) consummated its initial public offering (“IPO”) of 34,500,000 units (the “Units”).The Units include 4,500,000 Units of the Company purchased pursuant to the full exercise of the over-allotment option provided for by the Underwriting Agreement (as defined below). Each Unit consists of one Class A ordinary share of the Company, par value $0.0001 per share (the “Class A Ordinary Shares”), and one-fourth of one redeemable warrant of the Company (“Warrant”), each whole Warrant entitling the holder thereof to purchase one Class A Ordinary Share for $11.50 per share. The Units were sold at a price of $10.00 per unit, generating gross proceeds to the Company of $345,000,000.

 

Substantially concurrently with the closing of the IPO, the Company completed the private sale of 6,266,667 warrants (the “Private Placement Warrants”) to Freedom Acquisition I LLC (the “Sponsor”) at a purchase price of $1.50 per Private Placement Warrant, generating gross proceeds to the Company of $9,400,000. The Private Placement Warrants are identical to the warrants sold as part of the Units in the IPO except that, so long as they are held by the Sponsor or its permitted transferees: (1) they will not be redeemable by the Company; (2) they (including the Class A Ordinary Shares issuable upon exercise of these warrants) may not, subject to certain limited exceptions, be transferred, assigned or sold by the Sponsor until 30 days after the completion of the initial business combination; (3) they may be exercised by the holders on a cashless basis; and (4) they (including the Class A Ordinary Shares issuable upon exercise of these warrants) are entitled to registration rights. 

 

A total of $345,000,000, comprised of $338,595,000 of the net proceeds from the IPO, including $12,075,000 of the underwriters’ deferred discount, and $6,405,000 of the proceeds of the sale of the Private Placement Warrants, was placed in a U.S.-based trust account at J.P. Morgan Chase Bank, N.A., maintained by Continental Stock Transfer & Trust Company, acting as trustee. Except with respect to interest earned on the funds in the trust account that may be released to the Company to pay its taxes, the funds held in the trust account will not be released from the trust account until the earliest of (i) the completion of the Company’s initial business combination, (ii) the redemption of all of the Company’s public shares if it is unable to complete its business combination within 24 months from the closing of the IPO, subject to applicable law, or (iii) the redemption of the Company’s public shares properly submitted in connection with a shareholder vote to approve an amendment to the Company’s amended and restated memorandum and articles of association (A) to modify the substance or timing of the Company's obligation to redeem 100% of its public shares if it does not complete an initial business combination within 24 months from the closing of the IPO or (B) with respect to any other material provision relating to shareholders' rights or pre-initial business combination activity.

 

In connection with the IPO, the Company entered into the following agreements, forms of which were previously filed as exhibits to the Company registration statement (File No. 333-25940):

 

 
·

An Underwriting Agreement, dated February 25, 2021, between the Company and J.P. Morgan Securities LLC, as representative of the several underwriters (the “Underwriting Agreement”).

   
 ·The Amended and Restated Memorandum and Articles of Association of the Company, dated  February 25, 2021.

 

 ·A Warrant Agreement, dated February 25, 2021, between the Company and Continental Stock Transfer & Trust Company, as warrant agent.

 

 ·A Letter Agreement, dated February 25, 2021, among the Company and its officers, directors and Freedom Acquisition I, LLC.

 

 ·An Investment Management Trust Agreement, dated February 25, 2021, between the Company and Continental Stock Transfer & Trust Company, as trustee.

 

 ·A Registration Rights Agreement, dated February 25, 2021, between the Company and certain security holders.

 

 

 

 ·An Administrative Services Agreement, dated February 25, 2021, between the Company and the Sponsor.

 

 ·A Private Placement Warrants Purchase Agreement, dated February 25, 2021, between the Company and the Sponsor.

 

 ·Indemnity Agreements, each dated February 25, 2021, between the Company and each of its executive officers and directors.

 

On February 25, 2021, the Company issued a press release, a copy of which is attached as Exhibit 99.1 to this Current Report on Form 8-K, announcing the pricing of the IPO. On March 2, 2021, the Company issued a press release, a copy of which is attached as Exhibit 99.2 to this Current Report on Form 8-K, announcing the closing of the IPO.

 

 

 

Item 9.01. Financial Statements and Exhibits.

(d)Exhibits

 

Exhibit No. Description
1.1 Underwriting Agreement, dated February 25, 2021, between the Company and J.P. Morgan Securities LLC, as representative of the several underwriters.
3.1 Amended and Restated Memorandum and Articles of Association.
4.1 Warrant Agreement, dated February 25, 2021, between the Company and Continental Stock Transfer & Trust Company, as warrant agent.
10.1 A Letter Agreement, dated February 25, 2021, among the Company and its officers and directors and Freedom Acquisition I LLC.
10.2 Investment Management Trust Agreement, dated February 25, 2021, between the Company and Continental Stock Transfer & Trust Company, as trustee.
10.3 Registration Rights Agreement, dated February 25, 2021, between the Company and certain security holders.
10.4 Administrative Services Agreement, dated February 25, 2021, between the Company and Freedom Acquisition I LLC.
10.5 Private Placement Warrants Purchase Agreement, dated February 25, 2021, between the Company and the Sponsor.
10.6 Indemnity Agreement, dated February 25, 2021, between the Company and Tidjane Thiam.
10.7 Indemnity Agreement, dated February 25, 2021, between the Company and Adam Gishen.
10.8 Indemnity Agreement, dated February 25, 2021, between the Company and Jamie Weinstein.
10.9 Indemnity Agreement, dated February 25, 2021, between the Company and David Poritz.
10.10 Indemnity Agreement, dated February 25, 2021, between the Company and Noreen Doyle.
10.11 Indemnity Agreement, dated February 25, 2021, between the Company and William Janetschek.
99.1 Press Release, dated February 25, 2021.
99.2 Press Release, dated March 2, 2021.

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: March 2, 2021

 

 

   FREEDOM ACQUISITION I CORP.  
       
       
   By:/s/ Adam Gishen 
    Name:Adam Gishen 
    Title:Chief Executive Officer